Radiant Biotherapeutics Revenue and Competitors
Employee Data
- Radiant Biotherapeutics has 21 Employees.
- Radiant Biotherapeutics grew their employee count by 17% last year.
Radiant Biotherapeutics's People
| Name | Title | Email/Phone |
|---|
Radiant Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 22 | 29% | N/A | N/A |
#2 | N/A | 9 | 29% | N/A | N/A |
#3 | $0.7M | 9 | -72% | $39.4M | N/A |
#4 | $0.9M | 11 | -83% | $23.8M | N/A |
#5 | $87.6M | 499 | 8% | N/A | N/A |
#6 | $2.8M | 18 | 13% | N/A | N/A |
#7 | $7.8M | 50 | -68% | N/A | N/A |
#8 | $13.5M | 96 | 30% | N/A | N/A |
#9 | $17.8M | 115 | -6% | N/A | N/A |
#10 | $0.9M | 11 | -39% | N/A | N/A |
What Is Radiant Biotherapeutics?
Radiant’s Multabody™ platform enables multi-valent, multi-specific antibodies that have the potential to transform the treatment of cancer, inflammation, infections and other heterogeneous diseases. This breakthrough in antibody engineering combines avidity – superior binding power – with multi-specificity to create multifunctional biologics with the potential to unlock biology not achievable with current antibodies. Multabodies are a new class of biologics built on a modular, fully human scaffold, simplifying development while leveraging existing antibody manufacturing processes. We are rapidly advancing this superior next-generation therapeutic platform for a variety of indications. Learn more at radiantbio.com.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/A
N/A
Total Funding
21
Number of Employees
N/A
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 21 | -51% | N/A |
#2 | $2.1M | 21 | 0% | N/A |
#3 | $4.3M | 21 | 0% | N/A |
#4 | $2.1M | 21 | N/A | N/A |
#5 | $2.1M | 21 | N/A | N/A |